|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 241/20 | |
| A61K 31/4965 | |||
| A61P 9/10 |
| (11) | Number of the document | 3344607 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16766424.2 |
| Date of filing the European patent application | 2016-09-02 | |
| (97) | Date of publication of the European application | 2018-07-11 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/050021 |
| Date | 2016-09-02 |
| (87) | Number | WO 2017/040872 |
| Date | 2017-03-09 |
| (30) | Number | Date | Country code |
| 201562213702 P | 2015-09-03 | US | |
| 201562250955 P | 2015-11-04 | US | |
| 201662343617 P | 2016-05-31 | US |
| (72) |
VILLALVA, Nidia, MX
CANTE, Ivon, MX
AYBAR, Martin, MX
RODRIGUEZ, Angel, MX
TORRES, Alejandro, Guillen, MX
KANTOR, Hana, CZ
GAVENDA, Ales, CZ
HERRERA, Hugo, MX
JEGOROV, Alexander, CZ
LOPEZ, Nydia, MX
|
| (73) |
Teva Pharmaceuticals International GmbH,
Schlüsselstrasse 12, 8645 Jona,
CH
|
| (54) | SOLID STATE FORMS OF SELEXIPAG |
| SOLID STATE FORMS OF SELEXIPAG |